by 30 Technology | Nov 1, 2018 | News
Thirty Holdings Limited completed a £25 million equity investment led by Morningside Ventures, a major investor in the global Life Science sector. The investment enables the Group to accelerate research and development. We are delighted to welcome Isaac Cheng to the...
by 30 Technology | Oct 1, 2018 | News
Thirty Holdings Limited established following a corporate restructure. The Company trading name will be 30 Technology with the name derived from the molecular weight of nitric oxide (30). Edixomed Limited is now a wholly owned subsidiary of Thirty Holdings, focusing...
by 30 Technology | Apr 1, 2018 | News
New results show that Edixomed’s revolutionary new wound care system, EDX110, can heal diabetic foot ulcers dramatically faster and more effectively than current standard care. “Diabetic foot ulcers are notoriously hard to heal and are the leading cause of...
by 30 Technology | Jan 1, 2018 | News
Breakthrough Technology to Prevent and Treat Antibiotic Resistant Infection New results announced at the recent Wounds UK conference and Eurobiofilms 2017 congress have provided the latest evidence that Edixomed, a UK biotechnology company, has developed a...
by 30 Technology | Nov 1, 2017 | News
Edixomed Granted US and EU Patent Protection for Their Nitric Oxide Generating Treatment System Edixomed have been granted Intellectual Property protection for their nitric oxide generating treatment system in both the EU and USA. The priority date for the patents is...
by 30 Technology | May 1, 2017 | News
Edixomed completes anti-microbial efficacy study An independent analysis performed by Perfectus Biomed and utilising the FDA stipulated AATCC Test Method 100-2004, indicates that the Company’s lead product has achieved the required bacterial and fungal reduction to...
Recent Comments